Apnimed raises $192M IPO for potential 2027 sleep apnea drug launch

Apnimed

AMBER Tx General

Strategy Notes

Keyword match: +3 relevant, -0 negative signals.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: $192M
Type: funding_program
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-08-04 OPEN → INELIGIBLE · The page is a news article about Apnimed's IPO, not a funding opportunity. There is no application process or eligibility criteria.